Long-circulating iron oxides for MR imaging
References (50)
- et al.
Biophysical drug targeting: magnetically responsive albumin microspheres
Methods Enzymol.
(1985) - et al.
Magnetic drug targeting. I. In vivo kinetics of radiolabelled magnetic drug carriers
Int. J. Pharm.
(1987) - et al.
Magnetic drug targeting. II. Targeted drug transport by magnetic microparticles: factors influencing therapertic effect
Int. J. Pharm.
(1987) - et al.
Dextran magnetite: a new relaxation agent and its application to T2 measurements in gel systems
J. Magn. Res.
(1978) - et al.
Ferromagnetic particles as contrast agents in T2 NMR imaging
Magn. Reson. Imaging
(1986) - et al.
MR imaging of slow axonal transport in vivo
Exp. Neurol.
(1993) - et al.
Effect of particle surface on biodistribution
J. Magn. Hydrodyn.
(1993) - et al.
Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes
Biochim. Biophys. Acta
(1994) - et al.
Regulating the fate of mRNA: the control of cellular iron metabolism
Cell
(1993) - et al.
Regional differences in rat brain displayed by fast MRI with superparamagnetic contrast agents
Magn. Reson. Imaging
(1988)
Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration
Magn. Reson. Imaging
(1994)
Pharmaceutical iron oxides for MR imaging
Rev. Magn. Reson. Med.
(1993)
Magnetic microspheres: a model system for site specific drug delivery in vivo
Magnetic microcapsules for targeted delivery of anticancer drugs
Appl. Biochem. Biotechnol.
(1984)
Contrast agents for magnetic resonance imaging
Ferromagnetic particles as contrast agents for magnetic resonance imaging of the liver and spleen
Magn. Reson. Med.
(1986)
Magnetite albumin microspheres: a new MR contrast material
Am. J. Roentgenol.
(1987)
Ferromagnetic contrast agents: a new approach
Magn. Res. Med.
(1986)
Ferromagnetic antibody relaxation technique
The use of dextran-magnetite for liver enhancement
Relaxation enhancement of the dog liver and spleen by biodegradable superparamagnetic particles in proton magnetic resonance imaging
Acta Radiol.
(1987)
Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system
Radiology
(1987)
Target specific nuclear magnetic resonance imaging with antibody-iron-oxide particles
Ultrasmall magnetic particles coated with polyethyleneglycol as contrast agent in MRI of experimental abscesses: an animal study in mini-pigs
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging
Radiology
(1990)
Cited by (385)
Functionalized magnetic nanoparticles for treating bone diseases
2023, Nanomedicine: Technologies and ApplicationsBiochemical changes of macrophages and U87MG cells occurring as a result of the exposure to iron oxide nanoparticles detected with the Raman microspectroscopy
2022, Spectrochimica Acta - Part A: Molecular and Biomolecular SpectroscopyCitation Excerpt :However, the mechanism of this process was probably different for macrophages and glioma cells. In the case of macrophages the internalization probably occurred through the phagocytosis, which for these cells is the most efficient way for endocytosis of particles with size 50–180 nm [41,42]. Therefore, IONPs with a 30 nm core size and a 87 nm hydrodynamic diameter, were possibly phagocytized by macrophages and after decomposition in the acidic environment of their lysosomes the residual Fe was built into aforementioned adducts [43].
Magnetic systems for cancer immunotherapy
2021, Acta Pharmaceutica Sinica BDiagnostic Applications of Ultrasmall Superparamagnetic Particles of Iron Oxide for Imaging Myocardial and Vascular Inflammation
2021, JACC: Cardiovascular ImagingNew method of creating hybrid of buprenorphine loaded rifampin/polyethylene glycol/alginate nanoparticles
2020, International Journal of Biological Macromolecules
Copyright © 1995 Published by Elsevier B.V.